Mediwelcome Healthcare 2025 ESG Report: Key Highlights and Implications for Investors

Mediwelcome Healthcare Management & Technology Inc. has released its 2025 Environmental, Social and Governance (ESG) Report, revealing a year of significant strategic transformation, robust compliance, and deepened commitment to sustainable growth. Below, we detail the most important disclosures and initiatives, with an emphasis on factors that may be material for shareholders and potentially influence the company’s valuation.

1. Strategic Transformation to Technology-Driven Platform

• Major Shift to AI and Blockchain in Healthcare: Mediwelcome has transitioned from a traditional healthcare market solution provider to an “intelligent technology-driven platform,” focusing on “AI vertical models for the healthcare industry + blockchain.” This upgrade is not just technological but strategic, positioning the company at the forefront of healthcare digitalisation.
  Potential Impact: Such a transformation, if successful, could unlock new markets, create high-value medical data assets, and drive scalability-driven premium growth, which is likely to be price sensitive.
• Giraffe Digital and Intelligent Integrated Platform: This core platform underpins the company’s new offerings, enabling more precise solutions for NGOs, healthcare institutions, and pharmaceutical customers. It also facilitates the creation of a digital asset trading ecosystem for medical intellectual property, converting expert knowledge into transferable digital assets.

2. ESG Governance and Stakeholder Engagement

• Board Oversight: The Board of Directors holds primary responsibility for ESG strategy, risk, and reporting. The group’s management is actively involved in risk assessment and management effectiveness, with clear accountability structures.
• Material Issues Identified: High-priority ESG issues for 2025 include product and service quality, data compliance and medical privacy, anti-corruption, employee rights, occupational health and safety, healthcare accessibility, and low-carbon operations.

3. Product Responsibility and Data Privacy

• Comprehensive Quality Control: Mediwelcome integrates AI governance with traditional quality control, employing a dual-validation mechanism (“medical experts + AI”) and blockchain for data security and rights confirmation.
• Intellectual Property Portfolio: As of 31 December 2025, the Group owns 64 registered trademarks, 106 software copyrights, 17 domain names, and various other IP assets in Mainland China—an important foundation for sustainable revenue and competitive advantage.
• Data Privacy and Security: The company strictly complies with the Personal Information Protection Law and the Data Security Law, employing blockchain to create a closed-loop data lifecycle. There were no reported data leaks, losses, or privacy complaints in 2025—critical for maintaining customer trust and regulatory compliance.

4. Environmental Performance and Climate Management

• Low Environmental Impact Operations: Operations are office-based, with minimal direct environmental impact. In 2025, total greenhouse gas (GHG) emissions were 50.50 tCO₂e (down 3.44% YOY), mainly from electricity (Scope 2: 90.42%). Paper usage declined 5.34% YOY, and overall energy and water consumption dropped 14.94% and 32.24%, respectively.
• 100% Electric Vehicle Office Fleet: All company vehicles are new energy vehicles, contributing to a 37.22% reduction in vehicle emissions.
• Climate Risk Management: The company has fully integrated climate risk into its three-tier risk management system, with specific short-, medium-, and long-term emission reduction goals. Notably, all climate targets are embedded in departmental KPIs, with progress reported semi-annually and considered for management compensation.
• Climate-Related Opportunities: Green operations enable cost savings, improved ESG ratings, and enhanced competitiveness for brand and partnerships.

5. Social Responsibility: Employment, Diversity, and Employee Well-being

• Labour Compliance: No violations related to child or forced labour. Annual turnover increased to 146 (from 133 in 2024), mainly due to organisational restructuring for cost efficiency.
• Diversity and Training: 165 employees (48% female), 100% trained, with average 1.5 training hours per employee. The Group maintains a merit-based, non-discriminatory recruitment policy.
• Occupational Health and Safety: Achieved zero work-related fatalities and accidents in 2025. 100% participation in health checks and social insurance.
• Corporate Culture: Extensive employee engagement through festivals, sports, and team-building activities.

6. Supply Chain, Compliance, and Anti-Corruption

• Supply Chain Oversight: The Group works with 3,516 suppliers, all subject to annual evaluations. Anti-corruption commitments are mandatory for suppliers and purchasers.
• ISO37001 Certification: Mediwelcome operates under the ISO37001 Anti-Bribery Management System, with no corruption-related lawsuits or incidents in 2025.
• Comprehensive Compliance System: Four-pronged control system covers quality, information security, data compliance, and anti-bribery, bolstered by multiple certifications (Classified Protection Level 3, ISO27001, ISO9001).

7. Community Contributions

• Healthcare Accessibility: The Group facilitated over 100,000 physician education sessions, 30,000+ patient education sessions, and 510,000+ online consultations in 2025, supporting the construction of specialty medical centres.
• Social Impact: Strong focus on rural children’s education and community well-being.

8. Financial and Operational Key Performance Indicators (KPIs)

• Total Revenue (2025): RMB 468.02 million
• Net Profit: RMB 6.98 million
• Research & Development Expenditure: RMB 27.94 million
• Internet Hospital Patient Registrations: 359,202
• Online Consultations: 512,439
• Customer Complaints: 0
• Corruption Lawsuits: 0
• Work-Related Fatalities/Accidents: 0

Potentially Price-Sensitive and Material Information for Shareholders

• Strategic Upgrade to AI + Blockchain: The company’s deep commitment to becoming a vertical AI platform and digital asset ecosystem in healthcare marks a significant strategic shift, opening up new business models and revenue streams.
• Strong Compliance and Zero Incidents: No material regulatory, data privacy, or corruption issues reported, reinforcing operational integrity—a key consideration for institutional investors.
• Improving Environmental Metrics: Continuous reduction in GHG emissions, energy, and resource consumption, with robust climate governance, positions Mediwelcome as a leader in sustainable medical technology—a potential factor for ESG-focused funds.
• Resilient Financials and R&D Commitment: Despite restructuring, Mediwelcome remains profitable and heavily invested in innovation (R&D spend: RMB 27.94 million).
• Robust IP Portfolio: The ongoing accumulation of software copyrights and trademarks strengthens the Group’s competitive moat.

Summary for Investors

Mediwelcome Healthcare’s 2025 ESG Report underscores a year of transformative change, operational resilience, and strong ESG practices. The company’s strategic repositioning as an AI- and blockchain-driven healthcare platform, alongside a robust compliance framework and positive environmental and social outcomes, may attract new investors, especially those focused on long-term sustainability and innovation. The absence of significant legal, environmental, or customer-related issues further enhances the Group’s risk profile.

Shareholders should monitor: The execution and monetisation of the AI + blockchain strategy, progress on ESG and climate goals, and continued financial performance as these elements may have direct implications on future share value.

Disclaimer: This article is based on Mediwelcome Healthcare Management & Technology Inc.’s 2025 ESG Report and is intended solely for informational purposes for investors. It does not constitute investment advice. All financial and operational data referenced herein are based on company disclosures. Investors should conduct their own due diligence and consult with professional advisors before making any investment decisions. The publisher accepts no liability for actions taken based on this article.

View MEDIWELCOME Historical chart here